IL2 and neoplasm: In mouse models of orthotopic pancreatic cancer, L19–IL-2 inhibited tumor growth and metastasis and achieved long-term tumor control, with immune-mediated mechanisms supported by increased macrophage and NK cell infiltration in tumor tissue (42).